INSPIREMD 1/18 DL-0001 Market Cap ($19.63 Million)
Market Cap & Net Worth: INSPIREMD 1/18 DL-0001 (II2)
INSPIREMD 1/18 DL-0001 market cap. INSPIREMD 1/18 DL-0001 (F:II2) has a market capitalization of $19.63 Million (€16.79 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #25021 globally and #2153 in its home market, demonstrating a 7.19% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INSPIREMD 1/18 DL-0001's stock price €0.36 by its total outstanding shares 46892979 (46.89 Million). Also see INSPIREMD 1/18 DL-0001 operating cash flow efficiency for how efficiently the company converts equity into cash flow.
INSPIREMD 1/18 DL-0001 Market Cap History (2016–2026)
INSPIREMD 1/18 DL-0001 market cap history from 2016 to 2026. Data shows change from $3.10 Trillion to $19.63 Million (-72.08% CAGR). Check current stock price of INSPIREMD 1/18 DL-0001 for real-time trading data and today's change.
INSPIREMD 1/18 DL-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INSPIREMD 1/18 DL-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore II2 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.28x
INSPIREMD 1/18 DL-0001's market cap is 9.28 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $137.06 Million | $4.50 Million | -$14.92 Million | 30.49x | N/A |
| 2022 | $45.35 Million | $5.17 Million | -$18.49 Million | 8.77x | N/A |
| 2023 | $130.48 Million | $6.21 Million | -$19.92 Million | 21.03x | N/A |
| 2024 | $140.35 Million | $7.01 Million | -$32.01 Million | 20.02x | N/A |
| 2025 | $83.33 Million | $8.98 Million | -$48.79 Million | 9.28x | N/A |
Competitor Companies of II2 by Market Capitalization
Companies near INSPIREMD 1/18 DL-0001 in the global market cap rankings as of November 4, 2026. Also see INSPIREMD 1/18 DL-0001 total assets for a full breakdown of the balance sheet.
Key companies related to INSPIREMD 1/18 DL-0001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of INSPIREMD 1/18 DL-0001 (2016–2026)
Market capitalization of INSPIREMD 1/18 DL-0001 from 2016 to today. Between 2016 and today, INSPIREMD 1/18 DL-0001's market cap moved from $3.10 Trillion to $ 19.63 Million, with a yearly change of -72.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €19.63 Million | -76.45% |
| 2025 | €83.33 Million | -40.62% |
| 2024 | €140.35 Million | +7.56% |
| 2023 | €130.48 Million | +187.68% |
| 2022 | €45.35 Million | -66.91% |
| 2021 | €137.06 Million | -39.74% |
| 2020 | €227.46 Million | -65.64% |
| 2019 | €661.98 Million | -86.00% |
| 2018 | €4.73 Billion | -96.96% |
| 2017 | €155.42 Billion | -94.98% |
| 2016 | €3.10 Trillion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of INSPIREMD 1/18 DL-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.63 Million USD |
| MoneyControl | $19.63 Million USD |
| MarketWatch | $19.63 Million USD |
| marketcap.company | $19.63 Million USD |
| Reuters | $19.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more